about
Functional impairment of microglia coincides with Beta-amyloid deposition in mice with Alzheimer-like pathologyRequirement of PEN-2 for stabilization of the presenilin N-/C-terminal fragment heterodimer within the gamma-secretase complexIdentification of distinct gamma-secretase complexes with different APH-1 variantsGamma-secretase complex assembly within the early secretory pathwayImmunoproteasome deficiency alters microglial cytokine response and improves cognitive deficits in Alzheimer's disease-like APPPS1 mice.Novel pentameric thiophene derivatives for in vitro and in vivo optical imaging of a plethora of protein aggregates in cerebral amyloidoses.Impairment of immunoproteasome function by β5i/LMP7 subunit deficiency results in severe enterovirus myocarditis.M2 polarized macrophages and giant cells contribute to myofibrosis in neuromuscular sarcoidosisNuclear translocation uncovers the amyloid peptide Aβ42 as a regulator of gene transcription.Impact of peripheral myeloid cells on amyloid-β pathology in Alzheimer's disease-like mice.Formation and maintenance of Alzheimer's disease beta-amyloid plaques in the absence of microgliaHigh-fat diet-induced brain region-specific phenotypic spectrum of CNS resident microglia.Conserved size and periodicity of pyramidal patches in layer 2 of medial/caudal entorhinal cortex.Microglia actions in Alzheimer’s disease.Length and overall sequence of the PEN-2 C-terminal domain determines its function in the stabilization of presenilin fragments.PEN-2 is an integral component of the gamma-secretase complex required for coordinated expression of presenilin and nicastrin.Luminescent conjugated oligothiophenes for sensitive fluorescent assignment of protein inclusion bodiesLymphocytes modulate innate immune responses and neuronal damage in experimental meningitis.Enhanced fluorescent assignment of protein aggregates by an oligothiophene-porphyrin-based amyloid ligand.Comparison of immunosorbent assays for the quantification of biomarkers for Alzheimer's disease in human cerebrospinal fluid.Novel γ-sarcoglycan-mutation affects cardiac function and N-terminal dystrophin expression.Evidence for age-dependent in vivo conformational rearrangement within Aβ amyloid deposits.The most fulminant course of the Marburg variant of multiple sclerosis-autopsy findings.Inhibition of IL-12/IL-23 signaling reduces Alzheimer's disease-like pathology and cognitive decline.Fetal akinesia caused by a novel actin filament aggregate myopathy skeletal muscle actin gene (ACTA1) mutation.An azide functionalized oligothiophene ligand--a versatile tool for multimodal detection of disease associated protein aggregates.Cellular origin and diagnostic significance of high-fluorescent cells in cerebrospinal fluid detected by the XE-5000 hematology analyzer.[Amyloidoses in neuropathology].Atypical prion protein conformation in familial prion disease with PRNP P105T mutation.Long-Term Stability of Alzheimer's Disease Biomarker Proteins in Cerebrospinal FluidInterleukin-12/23 deficiency differentially affects pathology in male and female Alzheimer's disease-like miceProminent amyloid plaque pathology and cerebral amyloid angiopathy in APP V717I (London) carrier - phenotypic variability in autosomal dominant Alzheimer's diseaseFragile X-associated tremor ataxia syndrome with co-occurrent progressive supranuclear palsy-like neuropathologyNeuroimmune interactions in Alzheimer's disease-New frontier with old challenges?Impact of TREM2 risk variants on brain region-specific immune activation and plaque microenvironment in Alzheimer's disease patient brain samplesA Patient-Derived Glioblastoma Organoid Model and Biobank Recapitulates Inter- and Intra-tumoral Heterogeneity
P50
Q27327835-CF3E9D39-C855-4071-B16F-9D59731C3CBBQ28252335-089D15A3-9AF4-45F5-BF39-EFCAD739242EQ28274942-7CDC0EB2-05DB-4338-A9EA-0CA7707EB35AQ28297818-23A80BE1-66D8-45BF-A29B-A82677B90F35Q33831029-8B0C8BA9-9D60-4994-BFB1-07EDD1554C46Q33916487-286BA0D3-F890-448A-963E-21745AE7FCACQ34016246-F1DBF5B2-9978-4E34-A719-1645DF23BE80Q34756244-F1E3D1DD-8FB8-4994-BDB4-A60EAC29E390Q35176787-2763E615-4D05-4153-B89C-7A4E3651F50FQ36180666-30F6F9A7-C0C6-4532-B4D5-C23A4F08041BQ36487090-AB14B2A3-5FF3-48E1-B869-7F704762DC22Q37191551-00530F49-2063-47D6-8010-843BB288A162Q37238188-30A33FBE-6CDD-452D-B7FF-C2BD91FD0B9CQ38162232-D14E4424-DCE6-48F0-A87E-121BC2C6A6EAQ40410384-21981DF5-852E-449D-8A37-A9066FA333D1Q40708428-CC1816E0-EEAC-462A-BB08-E47039D78AD7Q42103490-F9AE7C22-BC9D-416C-B7C8-0C01B1BB7BD2Q42948860-7CB6F64E-B6B9-4DF8-B9EF-3F0D1CEB7FB6Q43664322-67268E67-1B5F-4398-9FB1-7D7C81A49247Q46346474-D4BB5042-8E83-4539-8811-D2B8A86FADE7Q47821930-D271B257-EC96-4BAE-8588-EADBA3307DE2Q48114298-337D162B-6425-47A5-B667-52FA9BA9F174Q48254563-EE4F5600-6B11-4B83-99E0-E47ED8F5CB7FQ48281683-2F2718E1-CEFB-4B91-AB01-E1E255029AE2Q51553838-609E210F-6B0C-4E4C-8014-C7943D8182E2Q52874832-005CF185-D01B-4625-B981-831E97BADE7AQ52884415-F57DA847-7F24-4CBF-97ED-2335522594C2Q52911832-726138E3-A365-470A-A208-45E9A56DD153Q53680677-C793987F-B2ED-46E7-B690-82704E0D93C2Q56988463-D45D1B13-EC91-41AB-B0C8-7F4CDD10CDE4Q89461791-8177DB29-2EA9-4BB6-9ADA-3BEB714C2BD0Q90275269-1ADFDA50-C189-4AFE-965C-629442732778Q91005182-42546BF5-1237-4C60-9288-537B2FB9394FQ91170632-895037AD-1F07-4FFA-B50A-F0052FD4A86DQ92215890-4824D896-CE4B-4E0C-B0C9-F17D83DE91F4Q92296473-5D4FA861-7BB8-4C2F-A52D-720DC57A460A
P50
description
hulumtues
@sq
researcher
@en
wetenschapper
@nl
հետազոտող
@hy
name
Stefan Prokop
@ast
Stefan Prokop
@en
Stefan Prokop
@es
Stefan Prokop
@nl
Stefan Prokop
@sl
type
label
Stefan Prokop
@ast
Stefan Prokop
@en
Stefan Prokop
@es
Stefan Prokop
@nl
Stefan Prokop
@sl
prefLabel
Stefan Prokop
@ast
Stefan Prokop
@en
Stefan Prokop
@es
Stefan Prokop
@nl
Stefan Prokop
@sl
P106
P1153
8564962400
P21
P31
P3835
stefan-prokop1
P496
0000-0002-5633-2149